Download video

ARASENS: Will combining different treatments improve prostate cancer survival?

319 views

VJOncology

7 years ago

ARASENS: Will combining different treatments improve prostate cancer survival?

ARASENS: Will combining different treatments improve prostate cancer survival?

ARASENS: Will combining different treatments improve prostate cancer survival?
2:32
ARASENS: Will combining different treatments improve prostate cancer survival?
by VJOncology
ARASENS: the addition of darolutamide to ADT and docetaxel for the treatment of mHSPC
1:44
ARASENS: the addition of darolutamide to ADT and docetaxel for the treatment of mHSPC
by VJOncology
ARASENS: tolerability + pharmacokinetic analyses of combo therapy with DARO, ADT and DOC in mHSPC
1:53
ARASENS: tolerability + pharmacokinetic analyses of combo therapy with DARO, ADT and DOC in mHSPC
by VJOncology
GU ASCO Symposium 2022 Summary
12:24
GU ASCO Symposium 2022 Summary
by Grand Rounds in Urology
Combination Therapy in Hormone-Sensitive Prostate Cancer
13:15
Combination Therapy in Hormone-Sensitive Prostate Cancer
by Grand Rounds in Urology
Advanced Prostate Cancer Clinical Trials Update 2022
10:51
Advanced Prostate Cancer Clinical Trials Update 2022
by Grand Rounds in Urology
ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022
6:41
ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022
by European Society for Medical Oncology (ESMO)
Early Treatment Intensification for mCSPC: Optimising Patient Selection and Treatment
5:40
Early Treatment Intensification for mCSPC: Optimising Patient Selection and Treatment
by COR2ED The Heart of Medical Education
ARASENS: dialuramide plus ADT and docetaxel for metastatic hormone-sensitive prostate cancer
1:56
ARASENS: dialuramide plus ADT and docetaxel for metastatic hormone-sensitive prostate cancer
by VJOncology
Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC
3:34
Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC
by ecancer
OS sensitivity analysis of darolutamide, docetaxel and ADT in ARASENS
0:51
OS sensitivity analysis of darolutamide, docetaxel and ADT in ARASENS
by VJOncology
Triplet Therapy for Metastatic Hormone-sensitive Prostate Cancer
2:27
Triplet Therapy for Metastatic Hormone-sensitive Prostate Cancer
by ASCOcancer
New Approaches to Metastatic Hormone Sensitive Prostate Cancer
17:44
New Approaches to Metastatic Hormone Sensitive Prostate Cancer
by Grand Rounds in Urology
2022 ASCO Genitourinary Cancers Symposium Research Updates Webinar with Dr. Alexandra Sokolova
54:02
2022 ASCO Genitourinary Cancers Symposium Research Updates Webinar with Dr. Alexandra Sokolova
by ZERO Prostate Cancer
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer
49:20
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer
by PeerView Oncology
The role of Radium 223 in metastatic castration resistant prostate cancer
1:33
The role of Radium 223 in metastatic castration resistant prostate cancer
by VJOncology
Role of the addition of docetaxel to ADT in mHSPC
1:19
Role of the addition of docetaxel to ADT in mHSPC
by VJOncology
Prostate cancer update: practice-changing data?
4:44
Prostate cancer update: practice-changing data?
by VJOncology
Update on overall survival in ARCHES trial
2:04
Update on overall survival in ARCHES trial
by VJOncology
Advanced Prostate Cancer Triple Therapy Study Results from the 2023 ASCO-GU Conference
5:09
Advanced Prostate Cancer Triple Therapy Study Results from the 2023 ASCO-GU Conference
by PROCURE - Cancer Prostate